Syncom Formulations (India) Limited (BOM:524470)

Market Cap	20.21B
Revenue (ttm)	4.65B
Net Income (ttm)	494.35M
Shares Out	940.00M
EPS (ttm)	0.57
PE Ratio	37.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	567,850
Average Volume	1,322,152
Open	21.36
Previous Close	21.85
Day's Range	20.75 - 21.89
52-Week Range	12.31 - 27.94
Beta	1.16
RSI	60.38
Earnings Date	May 16, 2025

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of comm...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 998
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524470

Financial Performance

In 2024, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.